vTv Therapeutics Inc.
VTVT
$33.28
$0.491.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 216,600.00% | 216,600.00% | -- | -98.30% | -98.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 216,600.00% | 216,600.00% | -- | -98.30% | -98.30% |
| Cost of Revenue | 131.43% | 104.73% | 54.69% | 41.37% | 12.14% |
| Gross Profit | 165.97% | 209.56% | -69.64% | -54.74% | -23.12% |
| SG&A Expenses | 31.45% | 18.93% | 9.49% | 0.74% | 3.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 79.77% | 59.06% | 30.21% | 19.35% | 7.47% |
| Operating Income | 63.89% | 87.86% | -35.68% | -24.26% | -12.10% |
| Income Before Tax | 73.18% | 96.82% | -37.49% | -25.52% | 5.67% |
| Income Tax Expenses | -- | -- | -- | -100.00% | -100.00% |
| Earnings from Continuing Operations | 73.18% | 96.82% | -36.89% | -24.97% | 6.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -61.87% | -29.26% | -3.23% | 11.49% | -17.45% |
| Net Income | 75.68% | 112.05% | -46.11% | -28.21% | 3.08% |
| EBIT | 63.89% | 87.86% | -35.68% | -24.26% | -12.10% |
| EBITDA | 63.84% | 87.85% | -36.12% | -24.57% | -12.29% |
| EPS Basic | 75.57% | 79.14% | 1.93% | 26.61% | 54.41% |
| Normalized Basic EPS | 76.38% | 85.27% | -2.85% | 24.33% | 52.72% |
| EPS Diluted | 66.15% | 69.28% | 1.87% | 26.57% | 54.38% |
| Normalized Diluted EPS | 65.45% | 73.91% | -2.85% | 24.33% | 52.72% |
| Average Basic Shares Outstanding | 79.63% | 57.68% | 48.93% | 53.76% | 71.32% |
| Average Diluted Shares Outstanding | 88.46% | 66.58% | 48.93% | 53.76% | 71.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |